BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19623629)

  • 1. Dermatomyositis with inclusion body myositis pathology.
    Layzer R; Lee HS; Iverson D; Margeta M
    Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
    Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
    Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion body myositis long after dermatomyositis: a report of two cases.
    McCoy AL; Bubb MR; Plotz PH; Davis JC
    Clin Exp Rheumatol; 1999; 17(2):235-9. PubMed ID: 10342053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
    Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
    Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of edematous dermatomyositis.
    MrouƩ KH; Sharara NH; Rbeiz JG; Arayssi TK
    J Rheumatol; 2003 Dec; 30(12):2722-3. PubMed ID: 14719223
    [No Abstract]   [Full Text] [Related]  

  • 15. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
    Derk CT; Vivino FB; Kenyon L; Mandel S
    Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    Pruitt JN; Showalter CJ; Engel AG
    Ann Neurol; 1996 Jan; 39(1):139-43. PubMed ID: 8572661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological data in inflammatory myositis].
    Mikol J; Polivka M
    Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral ocular myositis as a late complication of dermatomyositis.
    Kokotis P; Theodossiadis P; Bouros C; Sfikakis PP
    J Rheumatol; 2005 Feb; 32(2):379-81. PubMed ID: 15693104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.